Brown Shoe Company’s Naturalizer brand announced today that it has
partnered again with artist, interior designer and TV personality David
Bromstad to bring his unique and bold vision to life in a collection of
shoes and accessories this fall.
Itron, Inc. (NASDAQ: ITRI), a world-leading technology and services
company, announced today that it has signed a four-year contract to
supply water meters to Evides Waterbedrijf, water supplier to 2.5
million customers in the Western Netherlands.
Expands manufacturing and distribution capacity
Installs interactive 3D innovation and learning center at 3DS headquarters
Extends R&D and engineering capabilities and capacity
Creates hundreds of new jobs and opportunities in Rock Hill area
ROCK HILL, S.C., Aug.
United Natural Foods, Inc. (Nasdaq: UNFI) (the "Company") today
announced that Steven Spinner, President and Chief Executive Officer,
will present at the Canaccord Genuity 34th Annual Growth Conference on
Thursday, August 14, 2014 at 4:00 p.m. ET in Boston, MA.
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company
focused on the discovery and development of G protein coupled receptor
(GPCR) biased ligands, today announced financial results for the quarter
ended June 30, 2014.
By Philip van Doorn, MarketWatch
Despite worries in the world, these companies' prospects are improving
-Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com
Investors have had no shortage of things to worry about.
The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of Intervest Bancshares Corporation (“Intervest” or the
“Company”) (NASDAQ: IBCA) relating to the proposed buyout of the Company
by Bank of the Ozarks, Inc. (“Ozarks”).
On July 31, 2014, Intervest and Ozarks jointly announced the signing of
a definitive agreement and plan of merger whereby Ozarks will acquire
all of the outstanding common stock of Intervest in a transaction valued
at approximately $228.5 million.
Sign-up for - SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Intervest Bancshares Corporation In Connection With The Proposed Sale Of The Company To Bank of the Ozarks, Inc. investment picks
Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
creating innovative personalized therapeutics for patients with
genetically defined cancers, reported pre-clinical data and early
clinical observations from an ongoing Phase 1 trial, being conducted in
collaboration with Eisai, the Institut Gustave Roussy, and the Institut
Bergonie, of EZH2 inhibitor EPZ-6438 (E7438) in patients with advanced
solid tumors and B-cell lymphomas.
By Anora Mahmudova and Carla Mozee, MarketWatch
Kate Spade tumbles, Intercept shares jump
-Anora Mahmudova; 415-439-6400; AskNewswires@dowjones.com
NEW YORK (MarketWatch) -- U.S. stocks ended Tuesday's choppy session slightly lower as investors remained jittery amid tension between Ukraine and Russia and lingering concerns about sectarian wars in the Middle East.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.